Structural Constraints of Vaccine-Induced Tier-2 Autologous HIV Neutralizing Antibodies Targeting the Receptor-Binding Site
Open Access
- 1 January 2016
- journal article
- Published by Elsevier in Cell Reports
- Vol. 14 (1) , 43-54
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domainsProceedings of the National Academy of Sciences, 2014
- Developmental pathway for potent V1V2-directed HIV-neutralizing antibodiesNature, 2014
- Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse VirusesScience, 2012
- Early Low-Titer Neutralizing Antibodies Impede HIV-1 Replication and Select for Virus EscapePLOS Pathogens, 2012
- Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate ConformationJournal of Virology, 2011
- Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical VariablesJournal of Virology, 2010
- PHENIX: a comprehensive Python-based system for macromolecular structure solutionActa Crystallographica Section D Structural Biology, 2010
- MolProbity: all-atom contacts and structure validation for proteins and nucleic acidsNucleic Acids Research, 2007
- Coot: model-building tools for molecular graphicsActa Crystallographica Section D Structural Biology, 2004
- Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?The Lancet, 1992